Targeting AR in prostate cancer with siRNA. Targeting AR in prostate cancer with siRNA
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
We investigated the role of AR in castration-resistant prostate cancer cells using AR siRNA. Overall design: LNCaP MDV-3100/enzalutamide-resistant (MDV-R) cells were transfected with siRNA against AR or non-targeting control (siNT). RNA was extracted 72h post-transfection.
创建时间：
2020-03-19
